Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial
We aimed to assess the effects of the antioxidant-rich Mediterranean diet (MedDiet) on white blood cell count. Our study population included participants in the PREvención con DIeta MEDiterránea study (average age 67 years old, 58% women, high cardiovascular risk). We assessed whether a MedDiet inte...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Foods |
Subjects: | |
Online Access: | https://www.mdpi.com/2304-8158/10/6/1268 |
id |
doaj-dd63f85cdfbd41658e509ec8388df346 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Álvaro Hernáez Camille Lassale Sara Castro-Barquero Nancy Babio Emilio Ros Olga Castañer Anna Tresserra-Rimbau Xavier Pintó Miguel Ángel Martínez-González Dolores Corella Jordi Salas-Salvadó Ángel M. Alonso-Gómez José Lapetra Miquel Fiol Enrique Gómez-Gracia Lluis Serra-Majem Emilio Sacanella Ana García-Arellano José V. Sorlí Andrés Díaz-López Montserrat Cofán Ramón Estruch |
spellingShingle |
Álvaro Hernáez Camille Lassale Sara Castro-Barquero Nancy Babio Emilio Ros Olga Castañer Anna Tresserra-Rimbau Xavier Pintó Miguel Ángel Martínez-González Dolores Corella Jordi Salas-Salvadó Ángel M. Alonso-Gómez José Lapetra Miquel Fiol Enrique Gómez-Gracia Lluis Serra-Majem Emilio Sacanella Ana García-Arellano José V. Sorlí Andrés Díaz-López Montserrat Cofán Ramón Estruch Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial Foods white blood cell count Mediterranean diet leukopenia leukocytosis randomized controlled trial prevention |
author_facet |
Álvaro Hernáez Camille Lassale Sara Castro-Barquero Nancy Babio Emilio Ros Olga Castañer Anna Tresserra-Rimbau Xavier Pintó Miguel Ángel Martínez-González Dolores Corella Jordi Salas-Salvadó Ángel M. Alonso-Gómez José Lapetra Miquel Fiol Enrique Gómez-Gracia Lluis Serra-Majem Emilio Sacanella Ana García-Arellano José V. Sorlí Andrés Díaz-López Montserrat Cofán Ramón Estruch |
author_sort |
Álvaro Hernáez |
title |
Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial |
title_short |
Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial |
title_full |
Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial |
title_fullStr |
Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial |
title_full_unstemmed |
Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial |
title_sort |
mediterranean diet and white blood cell count—a randomized controlled trial |
publisher |
MDPI AG |
series |
Foods |
issn |
2304-8158 |
publishDate |
2021-06-01 |
description |
We aimed to assess the effects of the antioxidant-rich Mediterranean diet (MedDiet) on white blood cell count. Our study population included participants in the PREvención con DIeta MEDiterránea study (average age 67 years old, 58% women, high cardiovascular risk). We assessed whether a MedDiet intervention enriched in extra-virgin olive oil or nuts, versus a low-fat control diet, modified the incidence of leukocytosis (>11 × 10<sup>9</sup> leukocytes/L), mild leukopenia (<4.5 × 10<sup>9</sup> leukocytes/L), or severe leukopenia (<3.5 × 10<sup>9</sup> leukocytes/L) in individuals without the condition at baseline (<i>n</i> = 3190, <i>n</i> = 2925, and <i>n</i> = 3190, respectively). We also examined whether MedDiet modified the association between leukocyte count alterations and all-cause mortality. Both MedDiet interventions were associated with a lower risk of developing leukopenia (incidence rates: 5.06% in control diet, 3.29% in MedDiet groups combined; hazard ratio [95% confidence interval]: 0.54 [0.36–0.80]) and severe leukopenia (incidence rates: 1.26% in control diet, 0.46% in MedDiet groups combined; hazard ratio: 0.25 [0.10–0.60]). High cumulative adherence to a MedDiet was linked to lower risk of leukocytosis (incidence rates: 2.08% in quartile 1, 0.65% in quartile 4; HR<sub>Q4-Q1</sub>: 0.29 [0.085–0.99]) and attenuated the association between leukopenia and all-cause mortality (<i>P</i>-interaction = 0.032). In brief, MedDiet decreased the incidence of white blood cell count-related alterations in high cardiovascular risk individuals. |
topic |
white blood cell count Mediterranean diet leukopenia leukocytosis randomized controlled trial prevention |
url |
https://www.mdpi.com/2304-8158/10/6/1268 |
work_keys_str_mv |
AT alvarohernaez mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT camillelassale mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT saracastrobarquero mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT nancybabio mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT emilioros mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT olgacastaner mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT annatresserrarimbau mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT xavierpinto mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT miguelangelmartinezgonzalez mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT dolorescorella mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT jordisalassalvado mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT angelmalonsogomez mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT joselapetra mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT miquelfiol mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT enriquegomezgracia mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT lluisserramajem mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT emiliosacanella mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT anagarciaarellano mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT josevsorli mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT andresdiazlopez mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT montserratcofan mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial AT ramonestruch mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial |
_version_ |
1721352166708346880 |
spelling |
doaj-dd63f85cdfbd41658e509ec8388df3462021-06-30T23:08:03ZengMDPI AGFoods2304-81582021-06-01101268126810.3390/foods10061268Mediterranean Diet and White Blood Cell Count—A Randomized Controlled TrialÁlvaro Hernáez0Camille Lassale1Sara Castro-Barquero2Nancy Babio3Emilio Ros4Olga Castañer5Anna Tresserra-Rimbau6Xavier Pintó7Miguel Ángel Martínez-González8Dolores Corella9Jordi Salas-Salvadó10Ángel M. Alonso-Gómez11José Lapetra12Miquel Fiol13Enrique Gómez-Gracia14Lluis Serra-Majem15Emilio Sacanella16Ana García-Arellano17José V. Sorlí18Andrés Díaz-López19Montserrat Cofán20Ramón Estruch21August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainDepartment of Preventive Medicine and Public Health, Universidad de Málaga, 29071 Málaga, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainWe aimed to assess the effects of the antioxidant-rich Mediterranean diet (MedDiet) on white blood cell count. Our study population included participants in the PREvención con DIeta MEDiterránea study (average age 67 years old, 58% women, high cardiovascular risk). We assessed whether a MedDiet intervention enriched in extra-virgin olive oil or nuts, versus a low-fat control diet, modified the incidence of leukocytosis (>11 × 10<sup>9</sup> leukocytes/L), mild leukopenia (<4.5 × 10<sup>9</sup> leukocytes/L), or severe leukopenia (<3.5 × 10<sup>9</sup> leukocytes/L) in individuals without the condition at baseline (<i>n</i> = 3190, <i>n</i> = 2925, and <i>n</i> = 3190, respectively). We also examined whether MedDiet modified the association between leukocyte count alterations and all-cause mortality. Both MedDiet interventions were associated with a lower risk of developing leukopenia (incidence rates: 5.06% in control diet, 3.29% in MedDiet groups combined; hazard ratio [95% confidence interval]: 0.54 [0.36–0.80]) and severe leukopenia (incidence rates: 1.26% in control diet, 0.46% in MedDiet groups combined; hazard ratio: 0.25 [0.10–0.60]). High cumulative adherence to a MedDiet was linked to lower risk of leukocytosis (incidence rates: 2.08% in quartile 1, 0.65% in quartile 4; HR<sub>Q4-Q1</sub>: 0.29 [0.085–0.99]) and attenuated the association between leukopenia and all-cause mortality (<i>P</i>-interaction = 0.032). In brief, MedDiet decreased the incidence of white blood cell count-related alterations in high cardiovascular risk individuals.https://www.mdpi.com/2304-8158/10/6/1268white blood cell countMediterranean dietleukopenialeukocytosisrandomized controlled trialprevention |